High content screening for human primary pancreatic cell type-specific toxicants
Ended Definitive Contract Awarded Last action
- Contract number
- HHSN271201500032C
- Awardee
-
Zen-Bio, Inc. UEI LQS2WJFBBUQ3
- Awarding agency
-
National Center for Advancing Translational Sciences
National Institutes of Health, Department of Health and Human Services
- Obligated
- $224,901
Award facts
- Opportunity
-
- PHS20151 Solicitation number
- A solicitation of the national institutes of health (NIH) and the centers for disease control and prevention (CDC) for small business innovation research (sbir) contract proposals Award Notice · Posted Jul 31, 2014
- Contract value 100% obligated
- $224,901.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 8 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Durham, NC 27709, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | $0 | |
| Original award | $224,901 |
About this award
This is a firm fixed-price definitive contract awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency, to Zen-Bio, Inc. (doing business as Zenbio), a for-profit manufacturer of human blood products and related biological services. The $224,901 contract is for high content screening to identify human primary pancreatic cell type-specific toxicants. This is a small business set-aside contract with a completion date of March 14, 2016. Zenbio has been awarded multiple federal contracts by agencies like the CDC, NHLBI, and DHA to supply specialized biological materials for medical research and public health initiatives, demonstrating the company's expertise in supporting government research programs.
Quick answers
Who was awarded contract HHSN271201500032C?
HHSN271201500032C was awarded to Zen-Bio, Inc. by National Center for Advancing Translational Sciences (National Institutes of Health) on June 11, 2015.
How much is contract HHSN271201500032C worth?
The government has obligated $224,901 on HHSN271201500032C.
Was contract HHSN271201500032C competed?
The extent of competition for HHSN271201500032C was full and open competition after exclusion of sources. The government received 8 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award